Distinct Mechanisms of Type 3 Secretion System Recognition Control LTB4Synthesis in Neutrophils versus Macrophages

Distinct Mechanisms of Type 3 Secretion System Recognition Control LTB4 Synthesis in Neutrophils versus Macrophages | bioRxiv /* */ /* */ <!-- <!-- /*! * yepnope1.5.4 * (c) WTFPL, GPLv2 */ (function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split("="),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-M677548'); Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search New Results Distinct Mechanisms of Type 3 Secretion System Recognition Control LTB 4 Synthesis in Neutrophils versus Macrophages Amanda Brady , Leonardo C. Mora-Martinez , Benjamin Hammond , View ORCID Profile Bodduluri Haribabu , Silvia M. Uriarte , View ORCID Profile Matthew B. Lawrenz doi: https://doi.org/10.1101/2024.07.01.601466 Amanda Brady 1 Department of Microbiology and Immunology, University of Louisville School of Medicine , Louisville, Kentucky, United States of America Find this author on Google Scholar Find this author on PubMed Search for this author on this site Leonardo C. Mora-Martinez 1 Department of Microbiology and Immunology, University of Louisville School of Medicine , Louisville, Kentucky, United States of America Find this author on Google Scholar Find this author on PubMed Search for this author on this site Benjamin Hammond 1 Department of Microbiology and Immunology, University of Louisville School of Medicine , Louisville, Kentucky, United States of America Find this author on Google Scholar Find this author on PubMed Search for this author on this site Bodduluri Haribabu 1 Department of Microbiology and Immunology, University of Louisville School of Medicine , Louisville, Kentucky, United States of America 2 Center for Microbiomics, Inflammation and Pathogenicity , Louisville, Kentucky, United States of America Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Bodduluri Haribabu Silvia M. Uriarte 3 Deptartment of Oral Immunology & Infectious Diseases, University of Louisville , Louisville, Kentucky, United States of America 4 Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases , Louisville, Kentucky, United States of America Find this author on Google Scholar Find this author on PubMed Search for this author on this site Matthew B. Lawrenz 1 Department of Microbiology and Immunology, University of Louisville School of Medicine , Louisville, Kentucky, United States of America 4 Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases , Louisville, Kentucky, United States of America Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Matthew B. Lawrenz For correspondence: matt.lawrenz{at}louisville.edu Abstract Full Text Info/History Metrics Preview PDF Abstract Leukotriene B4 (LTB 4 ) is critical for initiating the inflammatory cascade in response to infection. However, Yersinia pestis colonizes the host by inhibiting the timely synthesis of LTB 4 and inflammation. Here, we show that the bacterial type 3 secretion system (T3SS) is the primary pathogen associated molecular pattern (PAMP) responsible for LTB 4 production by leukocytes in response to Yersinia and Salmonella , but synthesis is inhibited by the Yop effectors during Yersinia interactions. Moreover, we unexpectedly discovered that T3SS-mediated LTB 4 synthesis by neutrophils and macrophages require two distinct host signaling pathways. We show that the SKAP2/PLC signaling pathway is essential for LTB 4 production by neutrophils but not macrophages. Instead, phagocytosis and the NLRP3/CASP1 inflammasome are needed for LTB 4 synthesis by macrophages. Finally, while recognition of the T3SS is required for LTB 4 production, we also discovered a second unrelated PAMP-mediated signal independently activates the MAP kinase pathway needed for LTB 4 synthesis. Together, these data demonstrate significant differences in the signaling pathways required by macrophages and neutrophils to quickly respond to bacterial infections. Significance The production of inflammatory lipid mediators by the host is essential for timely inflammation in response to invasion by bacterial pathogens. Therefore, defining how immune cells recognize pathogens and rapidly produce these lipids is essential for us to understand how our immune system effectively controls infection. In this study, we discovered that the host signaling pathways required for leukotriene B4 (LTB 4 ) synthesis differ between neutrophils and macrophages, highlighting important differences in how immune cells respond to infection. Together, these data represent a significant improvement in our understanding of how neutrophils and macrophages rapidly react to bacteria and provide new insights into how Yersinia pestis manipulates leukocytes to evade immune recognition to cause disease. Introduction Rapid recruitment of immune cells to sites of infection is essential to control bacterial pathogens. However, sustained or chronic inflammation is detrimental to the host. Therefore, inflammation is a tightly regulated cascade of events controlled by both lipid and protein mediators ( 1 ). Initiation of this cascade is primarily mediated by inflammatory lipids, of which the eicosanoid leukotriene B4 (LTB 4 ) is one of the earliest produced during infection. LTB 4 is a potent pro-inflammatory chemoattractant and immune cell activator necessary for timely recruitment of neutrophils to sites of infections ( 1 – 6 ). LTB 4 is derived from arachidonic acid (AA) upon activation of the enzymes cytosolic phospholipase A 2 (cPLA 2 ) and 5-lipoxygenase (5-LOX). The enzymes are activated by phosphorylation via MAPK signaling and Ca 2+ binding to translocate to the nuclear membrane or a lipidisome, where a complex is formed with 5-LOX activating protein (FLAP) ( 7 – 14 ). This complex converts AA to LTA 4 , which is rapidly converted to LTB 4 by LTA 4 hydrolase ( 7 , 8 ). Upon subsequent release, LTB 4 is recognized by the high affinity BLT1 receptor on immune cells to promote priming, activation, and chemotaxis. Mouse models that disrupt the host’s ability to produce or respond to LTB 4 are impaired in initiating inflammation and are significantly more susceptible to a variety of infections, demonstrating the importance of LTB 4 in inducing a robust inflammatory response required for effective clearance of pathogens ( 1 , 2 , 15 , 16 ). Plague is an acute infection caused by the bacterial pathogen Yersinia pestis . A hallmark manifestation of plague is a significant delay in the recruitment of immune cells to the sites of infection, allowing for bacterial colonization and replication ( 17 – 20 ). One of the key virulence determinants for Y. pestis to inhibit the immune system and colonize the host is the Ysc type 3 secretion system (T3SS) encoded on the pCD1 plasmid ( 21 , 22 ). This secretion system mediates direct translocation of bacterial effector proteins called Yops into host cells ( 22 – 25 ). During mammalian infection, Y. pestis primarily targets neutrophils and macrophages for T3SS-mediated injection of the Yops ( 26 – 28 ). Once inside host cells, the Yop effectors target specific host factors to inhibit phagocytosis, reactive oxygen species (ROS) synthesis, degranulation by neutrophils, and inflammatory cytokine and chemokine release that is required to recruit circulating leukocytes to infection sites ( 29 – 37 ). Moreover, the Yop proteins were recently shown to actively inhibit the synthesis of LTB 4 required for the initiation of the inflammatory cascade during pneumonic plague ( 37 , 38 ). However, in the absence of the Yop effectors, neutrophils interacting with Y. pestis can synthesize LTB 4 , but synthesis requires bacterial expression of the T3SS and the YopB/D translocase ( 38 ). These data indicate that the T3SS is a pathogen associated molecular pattern (PAMP) recognized by neutrophils that triggers signaling pathways that lead to inflammatory lipid synthesis. Previous studies in macrophages have established components of the T3SS induce inflammatory cell death pathways. In the absence of the Yops, the T3SS and YopB/D translocon proteins can induce NLRP3-dependent activation of the caspase 1 inflammasome, IL1-β secretion, and pyroptosis, which is inhibited by YopK ( 31 , 39 ). These studies suggest that T3SS-dependent LTB 4 synthesis by neutrophils may also require NLRP3/CASP1 inflammasome activation. However, LTB 4 synthesis in response to other stimuli is not dependent on inflammasome activation ( 11 , 40 , 41 ). Furthermore, infection of neutrophils with a strain of Y. pestis that lacks all the Yops except YopK does not inhibit LTB 4 synthesis in neutrophils ( 37 , 38 ), raising an alternative possibility for inflammasome-independent mechanisms leading to T3SS-dependent LTB 4 synthesis. Moreover, Yop effectors other than YopK that have not been directly linked to inflammasome inhibition – YpkA, YopE, YopJ, or YopH – are sufficient to independently inhibit LTB 4 synthesis by neutrophils ( 37 , 38 ), further supporting the latter hypothesis. Of these four Yop effectors, YopJ and YopH are intimately involved in MAPK and Ca 2+ signaling required for LTB 4 synthesis. YopJ is an acyltransferase that targets several kinases in the MAPK pathway ( 42 – 45 ), and Pulsifer et al. demonstrated that YopJ inhibition of ERK phosphorylation is sufficient to inhibit LTB 4 synthesis by human neutrophils ( 37 ). YopH is a tyrosine phosphatase that has been shown to target multiple proteins of the focal adhesion complex, including SKAP2, SLP-76, PRAM, Vav, and LCK ( 28 , 46 – 49 ). Through these interactions, YopH inhibits β1-integrin-mediated Ca 2+ flux by neutrophils during interactions with Y. pseudotuberculosis , raising the possibility that this kinase signaling hub might be involved in LTB 4 synthesis in response to the T3SS. In this study, we use Y. pestis Yop mutants to define the molecular mechanisms responsible for T3SS-dependent LTB 4 synthesis and discovered significant differences in the host factors required for T3SS-sensing and LTB 4 synthesis between neutrophils and macrophages. Results Neutrophil LTB 4 synthesis in response to Salmonella enterica Typhimurium is dependent on the SPI-1 T3SS LTB 4 synthesis in response to Y. pestis is dependent on the expression of the T3SS and the YopB/D translocon ( 38 ). Moreover, S. enterica Typhimurium, which encodes two T3SSs (SPI-1 and SPI-2), also induces an LTB 4 response in neutrophils, but whether synthesis required expression of the T3SSs was not tested ( 50 ). To determine if leukocyte sensing of the T3SSs of S. enterica Typhimurium was responsible for LTB 4 synthesis, bone marrow derived murine neutrophils (BMNs) were infected with S. enterica Typhimurium LT2 (ST+) or a mutant lacking both the Salmonella pathogenicity island 1 (SPI-1) and SPI-2 encoded type 3 export apparatuses (ΔSPI1/2). After 1 h of infection, LTB 4 synthesis was significantly elevated in ST+ infected BMNs ( Fig 1A , ST+ vs. UI, p≤0.0001) but it was not elevated in cells infected with the ΔSPI1/2 mutant ( Fig 1A , p= 0.1513). To determine the contribution of the individual T3SSs, BMNs were next infected with individual SPI-1 or SPI-2 mutants. No significant differences in recovered LTB 4 were observed between cells infected with the ΔSPI1/2 and ΔSPI1 mutant strains, but LTB 4 concentrations were significantly elevated in the ΔSPI2 mutant infected cells ( Fig 1A , ΔSPI1/2 vs. ΔSPI2, p≤0.0001). Together these data support that neutrophils not only sense the Y. pestis T3SS but also the SPI-1 T3SS of S. enterica Typhimurium to initiate a robust LTB 4 response. Download figure Open in new tab Fig. 1. T3SS-depedent LTB 4 synthesis is conserved in S. enterica Typhimurium and BMDMs. (A) Murine neutrophils (BMNs) or (C) Murine macrophages (BMDMs) were infected with S . enterica Typhimurium LT2 (ST+), mutants that lacked Salmonella T3SS SPI-1, SPI-2, or both SPI-1/2. (B) BMDMs were infected with Y. pestis, Y. pestis T3E, Y. pestis T3 (−) , a yopB mutant in the T3E background (ΔB), or ΔB complemented with yopB (ΔB::B). (D) BMDMs infected with Y. pestis, Y. pestis T3E, Y. pestis T3 (−) , or Y. pestis strains expressing only one Yop (+A = YpkA; +E = YopE; +H = YopH; +J = YopJ; +K = YopK; +M = YopM; or +T = YopT). (A) BMNs were infected at an MOI of 20 for 1 h. (B-D) BMDMs were infected at an MOI of 20 for 4 h. (A-D) LTB 4 was measured from supernatants by ELISA. Each symbol represents an independent biological infection, and the box plot represents the median of the group ± the range. UI = uninfected. ns = not significant. One-way ANOVA with Tukey’s post hoc test compared to each condition for A, C, and D, or Dunnett’s post hoc test compared to uninfected for B. *=p≤0.05, ***=p≤0.001, ****=p≤0.0001. For panel D, p values when compared to uninfected denoted as a=p≤0.05 or b=p≤0.0001, and when compared to Y. pestis T3E as c=p≤0.0001. Requirement for interactions with the YopB/D translocase for LTB 4 synthesis is conserved in macrophages While we have previously shown that LTB 4 synthesis by both neutrophils and M1-polarized macrophages in response to Y. pestis is dependent on the presence of the T3SS, we only demonstrated a requirement for the YopB/D translocase in neutrophils ( 38 ). To determine whether the YopB/D translocase is also required for LTB 4 synthesis by macrophages, M1-polarized bone marrow derived macrophages (BMDMs) were infected with Y. pestis , a Y. pestis strain expressing the T3SS but lacking all Yop effectors ( Y. pestis T3E), a Y. pestis strain lacking the pCD1 plasmid encoding the entire Ysc T3SS [ Y. pestis T3 (−) ], or a Y. pestis T3E yopB mutant that is defective in expression of the translocase that directly interacts with the host cell plasmid membrane ( 51 – 53 ). As previously observed for neutrophils ( 38 ), BMDMs also did not synthesize LTB 4 in response to Y. pestis T3 (−) or Y. pestis T3E yopB ( Fig 1B ). Normal LTB 4 synthesis was restored by yopB complementation ( Fig 1B , yopB ::c yopB ). To confirm that the S. enterica Typhimurium SPI-1 T3SS is also required for LTB 4 synthesis by macrophages, BMDMs were infected with ST+ or the ΔSPI1/2, ΔSPI1, or ΔSPI2 mutants. As observed for BMNs, BMDM synthesis of LTB 4 was dependent on the presence of the SPI-1 T3SS but not SPI-2 system ( Fig 1C ). These data show that like neutrophils, macrophages respond to bacterial T3SSs by rapidly synthesizing LTB 4 . Only YopJ is sufficient to inhibit LTB 4 synthesis by macrophages We have previously shown that YpkA, YopE, YopJ, or YopH are individually sufficient to inhibit LTB 4 synthesis in neutrophils ( 37 , 38 ). To determine if these Yop effectors could inhibit LTB 4 synthesis by macrophages, LTB 4 was measured from BMDMs infected with Y. pestis strains that expressed only one Yop effector. BMDMs infected with strains expressing YpkA, YopE, YopH, YopK, and YopT showed significant decreases in LTB 4 compared to those infected with Y. pestis T3E, but still produced significantly more LTB 4 than Y. pestis infected or uninfected cells ( Fig 1D ). However, BMDMs infected with a strain expressing only YopJ appeared to be completely inhibited in their ability to synthesize LTB 4 , producing concentrations similar to those recovered from cells infected with Y. pestis expressing all of the Yop effectors ( Fig 1D ; +J vs. Yp). YopM was the only effector that did not appear to have any impact on LTB 4 synthesis. When compared to the ability of individual Yop effectors to inhibit LTB 4 synthesis in neutrophils, these data suggest that the signaling pathways leading to LTB 4 in response to the T3SS may differ between macrophages and neutrophils. Bacterial phagocytosis enhances LTB 4 synthesis by macrophages but not neutrophils One important consequence of Yop intoxication of leukocytes is the inhibition of phagocytosis via the action of YpkA and YopE ( 54 , 55 ). Moreover, an important function of the SPI-1 T3SS of S. enterica Typhimurium is to induce phagocytosis ( 56 ). Because phagocytosis is required for LTB 4 synthesis by leukocytes interacting with crystalline silica ( 11 ) and Y. pestis and the ΔSPI-1 mutant do not elicit LTB 4 synthesis in both neutrophils and macrophages, we next asked if phagocytosis of Y. pestis T3E or ST+ was required for T3SS-dependent LTB 4 synthesis by treating BMNs and BMDMs with the phagocytosis inhibitor cytochalasin D (cytoD) prior to infection. In BMNs, while treatment with cytoD inhibited phagocytosis of Y. pestis T3E ( S1 Fig A-B ), it did not alter the ability to synthesize LTB 4 ( Fig 2A and B ), indicating that Yop-mediated inhibition of phagocytosis is not responsible for the inhibition of T3SS-mediated LTB 4 synthesis during Y. pestis infection in neutrophils. Additionally, as previously reported by Golenkina et al. ( 50 ), cytoD treatment increased LTB 4 synthesis by BMNs infected with ST+ ( Fig 2C ; p≤0.05), indicating that induction of phagocytosis by S. enterica Typhimurium is not required for T3SS-mediated LTB 4 synthesis. However, in contrast to neutrophils, when phagocytosis was inhibited in BMDMs ( S1 Fig C-D ), LTB 4 synthesis was reduced in response to both Y. pestis T3E ( Fig 2E ; p≤0.05) and ST+ ( Fig 2F ; p≤0.059). Interestingly, LTB 4 levels were still higher in the cytoD infected BMDMs than the uninfected BMDMs ( Fig. 2D ). Together, these data suggest that phagocytosis is not required for T3SS-mediated LTB 4 synthesis by neutrophils but enhances synthesis by macrophages. Download figure Open in new tab Fig. 2. Phagocytosis is not required for LTB 4 synthesis in BMNs but enhances LTB 4 synthesis by macrophages in response to Y. pestis . (A-C) BMNs or (D-F) BMDMs were untreated (green circles) or pretreated with cytochalasin D (10 μM, purple circles) for 30 min and were either (A,D) uninfected or infected with (B,E) Y. pestis T3E or (C,F) ST at an MOI of 20 for (A-C) 1 h or (D-F) 4 h. (A-F) LTB 4 was measured from supernatants by ELISA. Each symbol represents an independent biological infection, and the box plot represents the median of the group ± the range. UI = uninfected. ns = not significant. T-test with Welch’s post hoc test. *=p≤0.05. PLC signaling is required for LTB 4 synthesis in neutrophils but not macrophages Ca 2+ flux is required for the activation of cPLA 2 and 5-LOX ( 7 , 14 ). However, it is unclear if the T3SS induces Ca 2+ flux through Ca 2+ migration through the YopB/D translocase pore or via conventional Ca 2+ signaling. Phospholipase C (PLC) is the central mediator of conventional Ca 2+ signaling in the cell ( 57 – 60 ), and chemical inhibitors of PLC have been well characterized ( 61 , 62 ). Therefore, to determine if Ca 2+ signaling is required for T3SS-dependent LTB 4 synthesis, leukocytes were treated prior to infection with U73122, which inhibits PLCβ and PLCγ ( 61 , 63 , 64 ). When PLC signaling was inhibited, BMNs infected with the Y. pestis T3E mutant were no longer able to synthesize LTB 4 compared to untreated BMNs ( Fig 3A ), suggesting that PLC-mediated Ca 2+ signaling is required for LTB 4 synthesis. To ensure that U73122 treatment did not have off target effects on cPLA 2 or 5-LOX, U73122-treated BMNs were incubated with the Ca 2+ ionophore, A23187, which induces Ca 2+ flux and LTB 4 synthesis independent of PLC signaling ( 65 ). Within 10 min of A23187 treatment, U73122-treated BMNs were able to synthesize LTB 4 , supporting that U73122 treatment is not affecting the activity of cPLA 2 or 5-LOX ( Fig 3A ). In contrast to BMNs, U73122 treatment of Y. pestis T3E-infected BMDMs only modestly inhibited LTB 4 synthesis compared to untreated cells ( Fig 3B ; p≤0.05), suggesting PLC is not the primary source of Ca 2+ flux in macrophages. Together, these data suggest that the T3SS activates PLC-mediated Ca 2+ flux in neutrophils needed for LTB 4 synthesis, but alternative mechanisms are required for T3SS-induced LTB 4 synthesis in macrophages. Download figure Open in new tab Fig. 3. PLC signaling is required for LTB 4 synthesis in BMNs. (A) BMNs or (B) BMDMs were infected with Y. pestis, Y. pestis T3E, or Y. pestis T3 (−) at an MOI of 20 for (A) 1 h or (B) 4 h. Leukocytes pretreated with PLC inhibitor (U73122; (A) 5 μM or (B) 20 μM) for 30 min (purple circles). (A) BMN supernatants were replaced with fresh media and cells were treated with A23187 (1 μM) for 10 min after treatment with U73122 for 30 min (orange circles). (A-B) LTB 4 was measured from supernatants by ELISA. Each symbol represents an independent biological infection, and the box plot represents the median of the group ± the range. UI = uninfected. One-way ANOVA with Tukey’s post hoc test compared to each condition. *=p≤0.05, ****=p≤0.0001. STIM1-mediated flux of extracellular Ca 2+ is required for LTB 4 synthesis in both neutrophils and macrophages PLC-mediated Ca 2+ flux is required for LTB 4 synthesis in neutrophils, but PLC signaling can lead to both Ca 2+ efflux from the ER and influx from the extracellular space ( 57 – 60 , 66 ). To determine if intracellular Ca 2+ efflux is sufficient to induce T3SS-dependent LTB 4 synthesis, BMNs were pre-treated with EGTA to chelate extracellular Ca 2+ prior to infection with Y. pestis T3E – if intracellular Ca 2+ efflux is sufficient for cPLA 2 and 5-LOX activation, then EGTA should not inhibit LTB 4 synthesis. As observed during PLC inhibition, EGTA chelation of extracellular Ca 2+ significantly reduced LTB 4 production compared to untreated BMNs ( Fig 4A ; p≤0.0001). Influx of extracellular Ca 2+ also requires the cell to maintain a membrane potential by efflux of intracellular potassium (K + ) ( 67 , 68 ). Therefore, if extracellular Ca 2+ is required, disrupting the K + gradient should also inhibit LTB 4 synthesis. As predicted by EGTA treatment, increasing the extracellular K + concentration significantly inhibited LTB 4 synthesis by Y. pestis T3E-infected BMNs ( Fig 4A ; p≤0.0001). Finally, we also treated BMNs with a pharmacological inhibitor of STIM1 (SKF), which activates SOC-mediated Ca + flux across the plasma membrane ( 69 ), and observed a significant decrease in LTB 4 synthesis ( Fig 4A ; p≤0.0001). Together, these data support that that extracellular Ca 2+ flux is required for the T3SS-dependent LTB 4 synthesis, and it is mediated by the PLC-STIM1 pathway in neutrophils. Interestingly, while PLC does not appear to be required for LTB 4 synthesis by macrophages ( Fig. 3 ), there remains a requirement for STIM1 and extracellular Ca 2+ flux ( Fig. 4B ), further indicating that alternative pathways are involved in triggering Ca 2+ flux needed for LTB 4 synthesis in macrophages. Download figure Open in new tab Fig. 4. Influx of extracellular Ca 2+ is required for Y. pestis T3SS-dependent LTB 4 synthesis. (A) BMNs or (B) BMDMs were infected with Y. pestis, Y. pestis T3E, or Y. pestis T3 (−) . Leukocytes pretreated with EGTA (1 mM; purple circles) for 30 min, with (A) 50 mM or (B) 100 mM KCl (orange circles) for 30 min, or with STIM1 inhibitor (SKF, 50 μM; white circles) for 2 min prior to infection with Y. pestis T3E. Leukocytes were infected at an MOI of 20 for (A) 1 h or (B) 4 h. LTB 4 was measured from supernatants by ELISA. Each symbol represents an independent biological infection, and the box plot represents the median of the group ± the range. UI = uninfected. One-way ANOVA with Tukey’s post hoc test compared to each condition. ****=p≤0.0001. SKAP2 is required for LTB 4 synthesis by neutrophils but not macrophages YopH inhibits PLC-mediated Ca 2+ flux in neutrophils during Y. pseudotuberculosis infection by modifying proteins of the SKAP2/SLP-76/PRAM/Vav signaling hub ( 28 , 48 , 49 ). Because YopH independently inhibits LTB 4 synthesis in neutrophils, we sought to determine if this hub is also required for T3SS-dependent LTB 4 synthesis by measuring LTB 4 synthesis by leukocytes from SKAP2 −/− mice infected with Y. pestis , Y. pestis T3E, or Y. pestis T3 (−) . Unlike BMNs from C57BL/6J mice, SKAP2 −/− BMNs did not synthesize LTB 4 in response to any of the strains tested ( Fig 5A ). To ensure that SKAP2 −/− BMNs were not generally defective in LTB 4 synthesis, SKAP2 −/− BMNs were treated with the Ca 2+ ionophore A23187, and cells robustly produced LTB 4 ( Fig 5B ). Complementing the PLC inhibitor data, SKAP2 −/− BMDMs were not impaired in LTB 4 synthesis ( Fig 5C ; p≤0.0001). Together, these data demonstrate that T3SS-dependent LTB 4 synthesis by neutrophils requires SKAP2 but is independent of SKAP2 in macrophages. Download figure Open in new tab Fig. 5. SKAP2 signaling required for LTB 4 synthesis in BMN. SKAP2 −/− . (A) BMNs or (C) BMDMs were infected with Y. pestis, Y. pestis T3E, or Y. pestis T3 (−) at an MOI of 20 for (A) 1 h or (C) 4 h. (B) SKAP2 −/− BMNs were treated with A23187 (1 μM; purple circles) for 1 h. (A-C) LTB 4 was measured from supernatants by ELISA. Each symbol represents an independent biological infection, and the box plot represents the median of the group ± the range. UI = uninfected. One-way ANOVA with Dunnett’s post hoc test compared to uninfected. ****=p≤0.0001. Activation of MAPK signaling required for LTB 4 synthesis is independent of the T3SS In addition to Ca 2+ flux, LTB 4 synthesis requires MAPK signaling to phosphorylate cPLA 2 and 5-LOX ( 7 , 70 – 72 ). While we previously showed that p38 and ERK1/2 are phosphorylated in human neutrophils infected with a high MOI (100 bacteria/cell) of Y. pestis T3 (−) ( 37 ), the MAP kinases responsible for T3SS-dependent LTB 4 synthesis have not been defined. Therefore, to determine whether p38 and ERK1/2 are phosphorylated during interactions with Y. pestis T3E, leukocytes were infected with Y. pestis , Y. pestis T3E, or Y. pestis T3 (−) at an MOI of 20. Both p38 and ERK1/2 were phosphorylated in BMNs infected with Y. pestis T3E but not Y. pestis ( Fig 6A-B ). For BMDMs, we observed elevated basal levels of p38 and ERK1/2 phosphorylation in uninfected cells, which has been reported in M1 polarized macrophages by others ( 73 – 76 ), but phosphorylation of both kinases was significantly lower in Y. pestis infected cells ( Fig 6C-D ). While p38 phosphorylation was slightly elevated in BMDMs infected with Y. pestis T3E, ERK1/2 phosphorylation appeared to decrease slightly, suggesting that p38 phosphorylation may be driving LTB 4 synthesis in BMDMs. However, in both leukocytes we observed similar trends in phosphorylation in cells infected with Y. pestis T3E or Y. pestis T3 (−) , indicating that activation of MAPK signaling is in response to a PAMP unrelated to the T3SS. Download figure Open in new tab Fig. 6. Activation of MAPK signaling required for LTB 4 synthesis is independent of the T3SS. (A-B) BMNs or (C-D) BMDMs were infected with Y. pestis, Y. pestis T3E, Y. pestis T3 (−) at an MOI of 20 for (A-B) 1 h or (C-D) 30 min. (A-B) BMNs were infected Y. pestis TE3 expressing only one Yop effector (+H = YopH; +J = YopJ) at an MOI of 20 for 1 h. Densitometry and representative WB images for (A,C) p-p38 or (B,D) p-ERK1/2 from whole cell lysates normalized to beta actin. (A-D) Each symbol represents an independent biological infection, and the box plot represents the median of the group ± the range. UI = uninfected. One-way ANOVA with Dunnett’s post hoc test compared to uninfected. *=p≤0.05, **=p≤0.01, ****=p≤0.0001. YopH inhibits ERK phosphorylation in neutrophils In BMNs, YopH and YopJ can independently inhibit LTB 4 synthesis. However, both effector proteins have different targets within the host cell, which can lead to inhibiting both Ca 2+ and/or MAPK signaling ( 22 , 29 ). While we have shown that YopJ inhibition of ERK1/2 phosphorylation is sufficient to block LTB 4 synthesis by human neutrophils ( 37 ), and Shaban et al. previously showed that YopH from Y. pseudotuberculosis inhibits ERK1/2 phosphorylation in neutrophils ( 49 ), whether YopH can also sufficiently inhibit ERK1/2 phosphorylation in our model has not been tested. Therefore, we measured ERK1/2 and p38 phosphorylation in BMNs infected with Y. pestis T3E strains expressing only YopH or YopJ. As predicted from our work with human neutrophils ( 37 ), phosphorylation of both MAP kinases was inhibited in BMNs infected with the YopJ expressing strain ( Fig 6A and B ; +J). However, infection with the YopH expressing strain appeared to only inhibit ERK1/2 phosphorylation and did not significantly impact p38 phosphorylation ( Fig 6A and B ; +H samples). These data suggest that YopH can block both Ca 2+ and ERK1/2 phosphorylation in neutrophils during interactions with Y. pestis . Inflammasome activation enhances LTB 4 synthesis in macrophages but not neutrophils Previous studies with Y. pseudotuberculosis indicate that the T3SS translocase is recognized by NLRP3, leading to activation of the caspase 1 inflammasome and pyroptosis ( 39 , 77 ). Inflammasome activation has been linked to LTB 4 synthesis in response to some PAMPS but is dispensable for others ( 11 , 40 , 41 ). Therefore, to determine if the NLRP3/CASP1 inflammasome contributes to LTB 4 synthesis in response to the T3SS, leukocytes isolated from NLRP3 −/− or CASP1/11 −/− mice were infected with Y. pestis , Y. pestis T3E, or Y. pestis T3 (−) , and LTB 4 synthesis was compared to cells isolated from WT mice. Absence of NLRP3 or CASP1/11 did not diminish the neutrophil response to Y. pestis T3E ( Fig 7A ). Furthermore, treatment of Y. pestis T3E infected BMNs or human PMNs with the pan-caspase inhibitor zVAD also did not decrease LTB 4 synthesis ( Fig 7B and C ). In contrast, LTB 4 synthesis was significantly lower in both NLRP3 and CASP1/11 deficient BMDMs ( Fig 7D ; p≤0.0001). However, LTB 4 synthesis by Y. pestis T3E infected cells was still greater than uninfected, Y. pestis , or Y. pestis T3 (−) infected cells, indicating that the NLRP3/CASP1 inflammasome enhances the LTB 4 response by macrophages but not neutrophils. Because CASP1/11 −/− macrophages still synthesized lower levels of LTB 4 in response to the Y. pestis T3E strain, we next asked if this synthesis was dependent on PLC signaling, and observed only a moderate decrease in LTB 4 when infected cells were treated with the PLC inhibitor U73122 ( Fig 7E ). Interestingly, we observed a much more significant decrease if we inhibited phagocytosis by treatment with cytoD or during infection with a Y. pestis T3E strain expressing only YopE, which is a potent inhibitor of phagocytosis ( Fig 7E ; p≤0.0001), suggesting that phagocytosis is key to initiating LTB 4 synthesis in macrophages. Download figure Open in new tab Fig. 7. Inflammasomes enhance LTB 4 synthesis in BMDMs but are dispensable in BMNs. (A) BMNS or (D) BMDMs from WT, NLRP3 −/− , CASP1/11 −/− mice were infected with Y. pestis, Y. pestis T3E, or Y. pestis T3 (−) . (B) C57BL/6J BMNs or (C) human PMNs (hPMNs) pretreated with zVAD inhibitor (100 μM; purple circles) for 30 min prior to infection with Y. pestis T3E. (E) BMDMs from CASP1/11 −/− mice were infected with Y. pestis T3E or Y. pestis T3E strain expressing only YopE (+E). BMDMs were either left untreated (green circles) or pretreated with PLC inhibitor (U73122, 20 μM; purple circles) or Cytochalasin D (10 μM; purple circles) for 30 min prior to infection with Y. pestis T3E. Leukocytes were infected at an MOI of 20 for (A-C) 1 h or (D-E) 4 h. (A-E) LTB 4 was measured from supernatants by ELISA. Each symbol represents an independent biological infection, and the box plot represents the median of the group ± the range. UI = uninfected. UT = untreated. ns = not significant. One-way ANOVA with Tukey’s post hoc test compared to each condition for A-D., or with Dunnett’s post hoc test compared to untreated/T3E for E. *=p≤0.05, **=p≤0.01, ***=p≤0.001, ****=p≤0.0001. Discussion Establishing a non-inflammatory environment during the early stages of plague is crucial for the progression of disease ( 20 ). We and others have shown that Y. pestis subverts the host innate immune response by inhibiting leukocyte chemotaxis ( 78 ), phagocytosis ( 32 , 33 ), neutrophil degranulation ( 36 , 37 ), neutrophil ROS production ( 33 , 35 ), and inflammatory lipid, cytokine, and chemokine release ( 34 , 37 , 38 ). Despite the T3SS being a PAMP, the Yop effectors are highly efficient at preventing immune cell activation, including inhibiting the synthesis of LTB 4 needed for a proper inflammatory host response ( 31 , 37 , 38 ). In this study, we sought to understand how the molecular signaling pathways stimulated by the T3SS lead to the synthesis of LTB 4 and to define how the pathogen uses specific Yop effectors to block this response. Using these data, we have developed a working model showing a differential response to the T3SS between neutrophils and macrophages needed for LTB 4 synthesis – with the SKAP2/PLC signaling pathway as key for a rapid response in neutrophils and the NLRP3/CASP1 inflammasome more important in macrophages ( Fig 8 ). Download figure Open in new tab Fig. 8. T3SS triggered LTB 4 synthesis differs between neutrophils and macrophages. LTB 4 synthesis requires an increase in intracellular Ca 2+ and activation of MAPK signaling. Activation of MAPK signaling required for LTB 4 synthesis appears to be independent of the T3SS, and instead is initiated by a currently unknown PAMP and signaling pathway(s) (Signal 1). In response to the T3SS (Signal 2), neutrophils require Ca 2+ signaling through SKAP2/PLC/STIM1 to produce LTB 4 . Macrophages require Ca 2+ influx from the extracellular space, with only a partial requirement of STIM1 but not SKAP2 or PLC. Inflammasome activation is not required in neutrophils for LTB 4 synthesis but enhances the induction in macrophages. Phagocytosis also enhances LTB 4 induction in macrophages, but not in neutrophils. Red boxes indicate factors involved in LTB 4 synthesis examined in this study. Blue boxes indicate potential or unknown factors they may be involved but have yet to be tested. One important discovery made here was that recognition of the T3SS leading to LTB 4 synthesis is not specific to the Y. pestis T3SS. While the S. enterica Typhimurium SPI-1 T3SS varies structurally from the Y. pestis secretion system ( 79 ), S. enterica Typhimurium still triggers LTB 4 in a SPI-1 T3SS-dependent manner ( Fig 1 ). Additionally, LTB 4 synthesis by S. enterica Typhimurium infected leukocytes appears to be more responsive to the SPI-1 T3SS than the SPI-2 system. Like the Y. pestis T3SS, the SPI-1 T3SS engages with the host cell through the plasma membrane, while SPI-2 engages through the Salmonella containing vacuole ( 80 , 81 ), suggesting that the host cells have evolved to sense T3SS interactions across the plasma membrane and respond by synthesizing LTB 4 . This scenario is attractive, as interactions with the plasma membrane represent the earliest interaction that leukocytes would have with pathogens and allow for rapid synthesis of the lipid as soon as contact is made. It also appears that unlike Y. pestis , S. enterica Typhimurium has not evolved effector proteins to inhibit this response, or at minimum, not to the degree that the Y. pestis Yop effectors can inhibit LTB 4 synthesis, as the WT S. enterica Typhimurium LT strain produces LTB 4 at levels similar to the Y. pestis T3E mutant. This difference supports that the inhibition of LTB 4, and initiation of the inflammatory cascade is an important aspect in the virulence and lifestyle of Y. pestis that is not required for S. enterica Typhimurium. A key virulence strategy mediated by the T3SSs of both Y. pestis and S. enterica Typhimurium is the manipulation of phagocytosis ( 46 , 82 ). Because phagocytosis of crystalline silica is required for LTB 4 synthesis ( 11 ), determining the contribution of phagocytosis to LTB 4 synthesis was another critical aspect of understanding the leukocyte response to these pathogens. In neutrophils, phagocytosis was not required for LTB 4 synthesis, and cytochalasin D treatment induced even greater LTB 4 synthesis in response to S. enterica Typhimurium. However, inhibiting phagocytosis reduced LTB 4 synthesis by macrophages, providing the first evidence that the host cell molecular mechanisms leading to cPLA 2 and 5-LOX activation and LTB 4 synthesis differ between these two cell types. It is important to note that for both bacteria, LTB 4 synthesis by macrophages was not completely inhibited by cytochalasin D treatment, indicating that synthesis is not completely dependent on phagocytosis in macrophages. Moreover, data from infections with the Y. pestis T3 (−) mutant, which is as readily phagocytosed as the Y. pestis T3E mutant, indicates that phagocytosis alone is not sufficient to trigger LTB 4 synthesis in the absence of the T3SS. Ca 2+ flux is a critical step in the enzyme activation required for LTB 4 synthesis ( 7 , 14 ), and thus understanding the mechanisms leading to Ca 2+ flux during host cell interactions with the T3SS expressing bacteria is key to understanding how cells are sensing this PAMP. YopB and YopD insert into the plasma membrane to form a pore needed for effector translocation into the host cell ( 51 – 53 ). Others have shown that the pore formed by the translocase can result in the diffusion of molecules larger than Ca 2+ , but YopN appears to limit diffusion through the YopB/D translocase ( 83 ). While the Y. pestis T3E strain used in these studies retains YopN, it is still possible that Ca 2+ diffusion through the translocase could occur in infected cells. However, using pharmacological inhibitors, we have shown that PLC and store-operated Ca 2+ signaling, and not diffusion of Ca 2+ through the translocase pore, is likely the primary driver of Ca 2+ flux needed for LTB 4 synthesis in neutrophils. This is further supported by the ability of YopH to inhibit LTB 4 synthesis, which blocks Ca 2+ flux by inhibiting PLC phosphorylation and signaling and not ion diffusion through the translocase ( 28 , 49 ), and the requirement for SKAP2, which activates PLC in response to signaling from a variety of tyrosine kinase receptors ( 84 , 85 ). Identifying which tyrosine kinase receptors are phosphorylating SKAP2 in response to the T3SS is an ongoing research direction for us and will help us to better understand the mechanisms directly sensing the T3SS and/or YopB/D translocase. Contrarily, because PLC pharmacological inhibition and YopH had minimal effects on LTB 4 synthesis in macrophages, the contribution of Ca 2+ diffusion through the translocase in macrophages is less clear. It appears that LTB 4 synthesis in macrophages still requires activation of STIM1 and store-operated calcium channels ( Fig. 5 ), indicating that diffusion of Ca 2+ through the pore is not sufficient to activate cPLA 2 and 5-LOX in macrophages, but also that the signal to activate STIM1 is independent of PLC. PLC-independent activation STIM1 has been reported, but activation requires Ca 2+ store depletion from the ER ( 86 , 87 ), suggesting that any Ca 2+ diffusion via the translocase pore is not directly responsible for STIM1 activation. Currently it is unclear how STIM1 is activated during macrophage interactions with the Y. pestis T3E strain and additional research is needed to completely understand the PLC-independent pathway(s) activated in macrophages. In addition to Ca 2+ flux, cPLA 2 and 5-LOX phosphorylation via MAPK signaling is also essential for LTB 4 synthesis ( 7 , 70 – 72 ). Depending on the stimulus, 5-LOX phosphorylation is mediated by p38, ERK1/2, or JNK ( 11 , 70 , 88 , 89 ), but while p38 and ERK1/2 are both phosphorylated in human neutrophils during interactions with Y. pestis T3E, only ERK1/2 was essential for LTB 4 synthesis ( 37 ). While we confirmed that both p38 and ERK1/2 are also phosphorylated in murine neutrophils and macrophages ( Fig 6 ), we also discovered that MAPK activation is not dependent on the presence of the T3SS, as we observed significant phosphorylation of the kinases in cells infected with the Y. pestis T3 (−) strain that lacks the pCD1 plasmid and the entire T3SS. These data indicate that a different PAMP(s) is triggering the MAPK pathway and that the host factors recognizing the T3SS and triggering Ca 2+ flux differ from those required for MAPK phosphorylation. A requirement for two signals is an important check point for other responses to bacteria, for example inflammasome activation, to limit premature inflammatory responses that could be detrimental to the host if stimulated too easily. Thus, to avoid chronic inflammation, a similar two signal check point may have also evolved to limit premature LTB 4 responses to bacteria. It is also currently unclear if this is specific for bacteria with T3SSs. Studies with other pathogens are needed to determine if multiple PAMPs/signals are also required for LTB 4 responses to bacteria that do not express T3SSs. Importantly, these data support that the primary signal governing whether LTB 4 is produced in recognition of the T3SS is Ca 2+ flux, not the MAPK activation. While BLT1-LTB 4 signaling has been shown to enhance inflammasome activation in gout ( 90 ), asthma ( 6 ), and Staphylococcus aureus skin infection models ( 91 ), evidence in the literature that inflammasome activation induces LTB 4 synthesis is limited. However, Von Moltke et al. showed that direct delivery of the NAIP5 ligand flagellin to the cytosol of resident peritoneal macrophages, but not M2 polarized BMDMS, triggers leukotriene and prostaglandin synthesis, which was dependent on NLRC4, NAIP5, and CASP1 ( 40 ). Moreover, they demonstrated that resident peritoneal macrophages produce prostaglandin E2 (PGE 2 ) in response to S. enteric Typhimurium, but they did not report LTB 4 synthesis or test dependence on the SPI1 T3SS ( 40 ). The new data reported here further support that polarization or activation state significantly impacts the potential of macrophages to synthesize eicosanoids during infection. Moreover, we have now identified a second example of a PAMP that triggers eicosanoid synthesis in an inflammasome-dependent manner and supports that inflammasome activation not only results in the release of protein mediators of inflammation (i.e., IL-1β and IL-18) but also lipid mediators of inflammation. The mechanisms leading to T3SS-dependent inflammasome-mediated LTB 4 synthesis are still unclear, but the MAPK data suggests that it is involved in triggering Ca 2+ flux, either directly or through the activation of STIM1 and the store-operated calcium channels. In conclusion, we have shown that leukocytes have evolved to recognize the T3SS as part of two signal cascade that leads to LTB 4 synthesis during bacterial interactions. However, the molecular mechanisms resulting in LTB 4 synthesis differ between neutrophils and macrophages, the former dependent on the SKAP2/PLC signaling pathway and the latter on the inflammasome. Together, these data provide us with a better understanding of the early response of leukocytes to bacterial pathogens and provide an example of how a pathogen, in this case Y. pestis , has evolved mechanisms to subvert these responses and evade the immune recognition to cause disease. Material and Methods Ethics statement All animal work was approved by the University of Louisville Institutional Animal Care and Use Committee (IACUC Protocol #22157). Use of human neutrophils was approved by the University of Louisville Institutional Review Board guidelines (IRB #96.0191) and written consents for use were obtained. Bacterial strains Bacterial strains used in this study are listed in S1 Table . Y. pestis was cultured with BHI broth for 15-18 h at 26°C in aeration. Cultures were then diluted 1:10 in fresh, warmed BHI broth containing 20 mM MgCl 2 and 20 mM Na-oxalate and cultured at 37°C for 3 h with aeration to induce expression of the T3SS. S. enterica Typhimurium was cultured with LB broth for 15-18 h at 37°C in aeration. Cultures were then diluted 1:10 in fresh, warmed LB broth and cultured at 37°C for 3 h with aeration to reach logarithmic growth. Bacterial concentrations were determined using a spectrophotometer and diluted to desired concentrations in fresh medium. Cell isolation and cultivation Murine leukocytes were isolated from bone marrow of 7-12-week-old mice that were either C57BL/6J, C57BL/6J Tyr −/− (B6 albino; Jackson Laboratory 000058), C57BL/6J Tyr −/− NLRP3 −/− , C57BL/6J Tyr −/− Caspase1/11 −/− , or BALB/c SKAP2 −/− . Murine neutrophils were isolated using an Anti-Ly-6G Microbeads kit (Miltenyi Biotec Cat. No. 130-120-337) per the manufacturer’s instructions. Neutrophil isolations yielded ≥ 95% purity and were used within 1 h of isolation. Macrophages were differentiated from murine bone marrow in DMEM supplemented with 1 mM Na-pyruvate, and 10% FBS for 6 days. Macrophages were polarized with 20 ng/mL of GM-CSF (Kingfisher Biotech Cat. No. RP0407M) throughout the differentiation. The medium was replaced on days 1 and 3 (adapted from ( 92 )). Human neutrophils were isolated from the peripheral blood of healthy, medication-free donors, as described previously ( 93 ). Neutrophil isolations yielded ≥ 95% purity and were used within 1 h of isolation. Leukocyte infections Human neutrophils were cultured in Kreb’s buffer (w/ Ca 2+ & Mg), mouse neutrophils (BMNs) were cultured in RPMI + 5% FBS, and macrophages (BMDMs) were cultured in DMEM + 10% FBS. Human neutrophils were adhered to 24-well plates for 30 min that were coated with pooled human serum prior to infection. BMNs were adhered to 24-well plates for 30 min that were coated with FBS prior to infection. Plates were washed twice with 1 x DPBS prior to plating the cells. BMDMs were adhered to 24-well plates 1 day prior to infection. Leukocytes were infected at a multiplicity of infection (MOI) of 20 and incubated for 1 h (neutrophils) or 4 h (macrophages) at 37°C with 5% CO 2 . All infections were synchronized by centrifugation (200 x g for 5 min). Supernatants and cells were then collected from wells to an Eppendorf tube and centrifuged for 1 min at 6,000 x g. Supernatants devoid of cells were transferred to a fresh tube and stored at −80°C until ELISA. When applicable, cell pellets were directly prepped for western blot analysis. Treatments and inhibitors Prior to infection, leukocytes were treated with the following for the times and concentrations indicated in the figure legends: phagocytosis inhibitor cytochalasin D (VWR; Cat. No. 100507-376), calcium ionophore A23187 (Sigma-Aldrich; Cat. No. C7522), PLC inhibitor U73122 (Abcam; Cat. No. ab120998), STIM1 inhibitor SKF-96365 (VWR; Cat. No. 89156-792), 1 mM EGTA, 50 mM or 100 mM KCl, or the pan-caspase inhibitor Z-Vad-FMK (Enzo; Cat. No. ALX-260-020). At the time of infection, bacteria were added for a 500 μL final volume. Measurement of LTB 4 by enzyme-linked immunosorbent assay Supernatants of neutrophils and macrophages were collected and measured for LTB 4 by ELISA per manufacturer’s instructions (Cayman Chemicals; Cat. No. 502390). Western blots Pellets were lysed over ice in 1x Novex lysis buffer and processed through Qiashredders (Qiagen; Cat. No. 79654). Samples were boiled for 10 min, and 10 μL was separated on a 10% SDS-PAGE gel. Samples were immunoblotted with polyclonal anti-p-p38 (Cell Signaling; Cat. No. 9211S), anti-p38 (Cell Signaling; Cat. No. 9228), anti-p-p44/42 (ERK1/2) (Cell Signaling; Cat. No. 9101s), anti-p44/42 (Cell Signaling; Cat. No. 4696), anti-beta-actin (Cell Signaling; Cat. No. 3700s). All antibodies were diluted 1:1000 or except anti-p44/42, which was diluted 1:2,000. Anti-rabbit (Sigma-Aldrich; Cat. No. A9169) or anti-mouse (ThermoFisher Scientific; Cat. No. 31430) IgG HRP secondary antibodies were diluted to 1:20,000. SuperSignal West Femto maximum-sensitivity substrate (ThermoFisher Scientific; cat. no. 34095) was used to detect antigen-antibody binding. Densitometry was performed using ImageJ software to quantify bands, normalized to beta actin. Confocal microscopy BMNs infected at an MOI of 10 with a GFP expressing Y. pestis T3E strain were pretreated with 10 μM cytochalasin D or DPBS. After 1 h of infection, cells were then fixed with 4% PFA (Sigma Aldrich; cat. no. P6148-500G), blocked with 3% BSA-PBS (Sigma; A4503-100G), stained with rabbit anti- Yersinia pestis sera (1:1,000; lot UL25, 9/14/2013) overnight at 4°C, followed by donkey anti-rabbit Alexa Fluor 647 (1:1,000; JacksonImmuno Research; cat. no. 711-605-152) for 2 hours at room temperature, and finally with Hoechst (1:350; cat. no. ThermoScientific; 62249) at room temperature for 15 minutes. Cells were then mounted in Prolong Gold (Invitrogen; cat. no. P36980) and visualized with z-stack images using a confocal Olympus Fluoview FV3000 UPlanxApo. To quantify the rates at which bacteria were phagocytosed, 3D volume Pearson correlation coefficients were calculated for eGFP and Alexa647. Statistics For all studies, male and female mice or human donors were used and no sex biases were observed for any phenotype. For all experiments, each data point represents data from biologically independent experiments performed on different days. Where appropriate and as indicated in the figure legends, statistical comparisons were performed with Prism (GraphPad) using one-way analysis of variance (ANOVA) with Dunnett’s or Tukey’s post hoc test, or T-test with Mann-Whitney’s post hoc test. P values ≤ 0.05 were considered statistically significant and reported. Funding This work was supported by funding from the National Institutes of Health NIAID T32AI132146 (AB), NIAID R01AI148241 (MBL), NIAID R01AI178106 (MBL), NIGMS P20GM125504 (MBL), and in part from the Jewish Heritage Foundation for Excellence Grant Program at the University of Louisville School of Medicine (MBL). Supplementary Info Download figure Open in new tab Figure S1. Cytochalasin D successfully inhibits BMN and BMDM phagocytosis of Y. pestis . (A-B) BMNs or (C-D) BMDMs were either left untreated (T3E) or pre-treated with cytochalasin D (10 μM; T3E / CD) for 30 min prior to infection with Y. pestis T3E at an MOI of 10 for (A-B) 1 h or (C-D) 4 h. (A,C) Representative confocal images of 3 biological replicates; eGFP=intracellular bacteria; Anti-Y.p.=extracellular bacteria. (B,D) Pearson scores calculated for eGFP and Anti-Y.p.-Alexa647 from 3 biological replicates, 3-4 images collected from each replicate. View this table: View inline View popup Download powerpoint Table S1. Bacterial strains and plasmids used in this study Acknowledgements The authors would like to thank Dr. Jon Goguen for sharing Y. pestis strains and Dr. Micah Worley for S. enterica Typhimurium strains used in these studies. We would also like to acknowledge Pathricia “Angel” Leus and Dr. Joan Mecsas for generously providing us with bone marrow from SKAP2 −/− mice and Dr. Jonathan Warawa for sharing Tyr −/− , NLRP3 −/− , and CASP1/11 −/− mice. References 1. ↵ C. D. Sadik , A. D. Luster , Lipid-cytokine-chemokine cascades orchestrate leukocyte recruitment in inflammation . J. Leukoc. Biol . 91 , 207 – 215 ( 2012 ). OpenUrl CrossRef PubMed Web of Science 2. ↵ P. V. Afonso et al. , LTB 4 is a signal-relay molecule during neutrophil chemotaxis . Dev. Cell 22 , 1079 – 1091 ( 2012 ). OpenUrl CrossRef PubMed 3. M. Peters-Golden , C. Canetti , P. Mancuso , M. J. Coffey , Leukotrienes: Underappreciated mediators of innate immune responses . J. Immunol . 174 , 589 – 594 ( 2005 ). OpenUrl Abstract / FREE Full Text 4. B. C. Subramanian , K. Moissoglu , C. A. Parent , The LTB 4 -BLT1 axis regulates the polarized trafficking of chemoattractant GPCRs during neutrophil chemotaxis . J. Cell Sci . 131 ( 2018 ). 5. A. Secatto et al. , The leukotriene B 4 /BLT 1 axis is a key determinant in susceptibility and resistance to histoplasmosis . PLoS ONE 9 , e85083 ( 2014 ). OpenUrl CrossRef PubMed 6. ↵ D. W. Kwak , D. Park , J. H. Kim , Leukotriene B 4 receptors are necessary for the stimulation of NLRP3 inflammasome and IL-1beta synthesis in neutrophil-dominant asthmatic airway inflammation . Biomedicines 9 ( 2021 ). 7. ↵ M. Wan , X. Tang , A. Stsiapanava , J. Z. Haeggstrom , Biosynthesis of leukotriene B 4 . Semin. Immunol . 33 , 3 – 15 ( 2017 ). OpenUrl 8. ↵ S. W. Crooks , R. A. Stockley , Leukotriene B4 . The International Journal of Biochemistry and Cell Biology 30 , 173 – 178 ( 1998 ). OpenUrl 9. J. Z. Haeggstrom , Leukotriene biosynthetic enzymes as therapeutic targets . J. Clin. Invest . 128 , 2680 – 2690 ( 2018 ). OpenUrl CrossRef PubMed 10. V. S. Hanna , E. A. A. Hafez , Synopsis of arachidonic acid metabolism: A review . J Adv Res 11 , 23 – 32 ( 2018 ). OpenUrl 11. ↵ B. Hegde et al. , Inflammasome-independent leukotriene B 4 production drives crystalline silica-induced sterile inflammation . J. Immunol . 200 , 3556 – 3567 ( 2018 ). OpenUrl Abstract / FREE Full Text 12. M. Peters-Golden , W. R. Henderson , Leukotrienes . The New England Journal of Medicine 357 ( 2007 ). 13. M. Peters-Golden , T. G. Brock , 5-Lipoxygenase and FLAP . Prostaglandins, Leukotrienes and Essential Fatty Acids 69 , 99 – 109 ( 2003 ). OpenUrl CrossRef PubMed Web of Science 14. ↵ M. Peters-Golden , K. Song , T. Marshall , T. Brock , Translocation of cytosolic phospholipase A2 topographically localized phospholipid hydrolysis . Biochemical Journal 318 , 797 – 803 ( 1996 ). OpenUrl Abstract / FREE Full Text 15. ↵ T. Yokomizo , Two distinct leukotriene B4 receptors, BLT1 and BLT2 . J. Biochem. 157 , 65 – 71 ( 2015 ). OpenUrl CrossRef PubMed 16. ↵ R. He , Y. Chen , Q. Cai , The role of the LTB 4 -BLT1 axis in health and disease . Pharmacol. Res . 158 , 104857 ( 2020 ). OpenUrl 17. ↵ C. Demeure et al. , Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination and diagnostics . Microbes Infect . 20 , 357 – 370 ( 2019 ). OpenUrl 18. C. F. Bosio , C. O. Jarrett , D. Gardner , B. J. Hinnebusch , Kinetics of innate immune response to Yersinia pestis after intradermal infection in a mouse model . Infect. Immun . 80 , 4034 – 4045 ( 2012 ). OpenUrl Abstract / FREE Full Text 19. L. K. Chung , J. B. Bliska , Yersinia versus host immunity: how a pathogen evades or triggers a protective response . Curr. Opin. Microbiol . 29 , 56 – 62 ( 2016 ). OpenUrl CrossRef 20. ↵ Y. Vagima et al. , Circumventing Y. pestis virulence by early recruitment of neutrophils to the lungs during pneumonic plague . PLoS Pathog . 11 , e1004893 ( 2015 ). OpenUrl CrossRef PubMed 21. ↵ B. Coburn , I. Sekirov , B. B. Finlay , Type III secretion systems and disease . Clin. Microbiol. Rev . 20 , 535 – 549 ( 2007 ). OpenUrl Abstract / FREE Full Text 22. ↵ R. D. Perry , J. D. Fetherston , Yersinia pestis —Etiologic agent of plague . Clin. Microbiol. Rev . 10 , 35 – 66 ( 1997 ). OpenUrl Abstract / FREE Full Text 23. R. S. Dewoody , P. M. Merritt , M. M. Marketon , Regulation of the Yersinia type III secretion system: traffic control . Front Cell Infect Microbiol 3 , 4 ( 2013 ). OpenUrl 24. C. Montagner , C. Arquint , G. R. Cornelis , Translocators YopB and YopD from Yersinia enterocolitica form a multimeric integral membrane complex in eukaryotic cell membranes . J. Bacteriol . 193 , 6923 – 6928 ( 2011 ). OpenUrl Abstract / FREE Full Text 25. ↵ T. R. Costa et al. , YopD self-assembly and binding to LcrV facilitate type III secretion activity by Yersinia pseudotuberculosis . J. Biol. Chem . 285 , 25269 – 25284 ( 2010 ). OpenUrl Abstract / FREE Full Text 26. ↵ M. M. Marketon , R. W. DePaolo , K. L. DeBord , B. Jabri , O. Schneewind , Plague bacteria target immune cells during infection . Science 309 , 1739 – 1741 ( 2005 ). OpenUrl Abstract / FREE Full Text 27. R. D. Pechous , V. Sivaraman , P. A. Price , N. M. Stasulli , W. E. Goldman , Early host cell targets of Yersinia pestis during primary pneumonic plague . PLoS Pathogens 9 , e1003679 ( 2013 ). OpenUrl CrossRef PubMed 28. ↵ H. G. Rolan , E. A. Durand , J. Mecsas , Identifying Yersinia YopH-targeted signal transduction pathways that impair neutrophil responses during in vivo murine infection . Cell Host Microbe 14 , 306 – 317 ( 2013 ). OpenUrl CrossRef PubMed 29. ↵ G. V. Plano , K. Schesser , The Yersinia pestis type III secretion system: expression, assembly and role in the evasion of host defenses . Immunol. Res . 57 , 237 – 245 ( 2013 ). OpenUrl CrossRef PubMed 30. S. Atkinson , P. Williams , Yersinia virulence factors - a sophisticated arsenal for combating host defences . F1000Res 5 ( 2016 ). 31. ↵ J. B. Bliska , X. Wang , G. I. Viboud , I. E. Brodsky , Modulation of innate immune responses by Yersinia type III secretion system translocators and effectors . Cell. Microbiol . 15 , 1622 – 1631 ( 2013 ). OpenUrl CrossRef PubMed 32. ↵ S. C. Dudte , B. J. Hinnebusch , J. G. Shannon , Characterization of Yersinia pestis interactions with human neutrophils In vitro . Front Cell Infect Microbiol 7 , 358 ( 2017 ). OpenUrl 33. ↵ J. L. Spinner , J. A. Cundiff , S. D. Kobayashi , Yersinia pestis type III secretion system-dependent inhibition of human polymorphonuclear leukocyte function . Infect. Immun . 76 , 3754 – 3760 ( 2008 ). OpenUrl Abstract / FREE Full Text 34. ↵ J. L. Spinner , A. M. Hasenkrug , J. G. Shannon , S. D. Kobayashi , B. J. Hinnebusch , Role of the Yersinia YopJ protein in suppressing interleukin-8 secretion by human polymorphonuclear leukocytes . Microbes Infect . 18 , 21 – 29 ( 2016 ). OpenUrl CrossRef 35. ↵ J. L. Spinner et al. , Neutrophils are resistant to Yersinia YopJ/P-induced apoptosis and are protected from ROS-mediated cell death by the type III secretion system . PLoS ONE 5 , e9279 ( 2010 ). OpenUrl CrossRef PubMed 36. ↵ K. R. Eichelberger , G. S. Jones , W. E. Goldman , Inhibition of Neutrophil Primary Granule Release during Yersinia pestis Pulmonary Infection . mBio 10 ( 2019 ). 37. ↵ A. R. Pulsifer et al. , Redundant and cooperative roles for Yersinia pestis yop effectors in the inhibition of human neutrophil exocytic responses revealed by gain-of-function approach . Infect. Immun . 88 , 1 – 16 ( 2020 ). OpenUrl CrossRef 38. ↵ A. Brady et al. , Type 3 secretion system induced leukotriene B4 synthesis by leukocytes is actively inhibited by Yersinia pestis to evade early immune recognition . PLoS Pathog . 20 , e1011280 ( 2024 ). OpenUrl 39. ↵ I. E. Brodsky et al. , A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system . Cell Host Microbe 7 , 376 – 387 ( 2010 ). OpenUrl CrossRef PubMed Web of Science 40. ↵ J. von Moltke et al. , Rapid induction of inflammatory lipid mediators by the inflammasome in vivo . Nature 490 , 107 – 111 ( 2012 ). OpenUrl CrossRef PubMed Web of Science 41. ↵ K. F. Zoccal et al. , Opposing roles of LTB 4 and PGE 2 in regulating the inflammasome-dependent scorpion venom-induced mortality . Nat Commun 7 , 10760 ( 2016 ). OpenUrl 42. ↵ G. I. Viboud , J. B. Bliska , Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis . Annu. Rev. Microbiol . 59 , 69 – 89 ( 2005 ). OpenUrl CrossRef PubMed Web of Science 43. L. E. Palmer , S. Hobbie , J. E. Galan , J. B. Bliska , YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-a production and downregulation of the MAP kinases p38 and JNK . Mol. Microbiol . 27 , 953 – 965 ( 1998 ). OpenUrl CrossRef PubMed Web of Science 44. A. Zauberman et al. , Interaction of Yersinia pestis with macrophages: limitations in YopJ-dependent apoptosis . Infect. Immun . 74 , 3239 – 3250 ( 2006 ). OpenUrl Abstract / FREE Full Text 45. ↵ N. Paquette et al. , Serine/threonine acetylation of TGFbeta-activated kinase (TAK1) by Yersinia pestis YopJ inhibits innate immune signaling . Proc. Natl. Acad. Sci. U. S. A . 109 , 12710 – 12715 ( 2012 ). OpenUrl Abstract / FREE Full Text 46. ↵ B. Grabowski , M. A. Schmidt , C. Ruter , Immunomodulatory Yersinia outer proteins (Yops): Useful tools for bacteria and humans alike . Virulence 8 , 1124 – 1147 ( 2017 ). OpenUrl 47. M. L. de la Puerta et al. , Characterization of new substrates targeted by Yersinia tyrosine phosphatase YopH . PLoS ONE 4 , e4431 ( 2009 ). OpenUrl CrossRef PubMed 48. ↵ D. S. Black , A. Marie-Cardine , B. Schraven , J. B. Bliska , The Yersinia tyrosine phosphatase YopH targets a novel adhesion-regulated signalling complex in macrophages . Cell. Microbiol . 2 , 401 – 414 ( 2000 ). OpenUrl CrossRef PubMed Web of Science 49. ↵ L. Shaban et al. , Yersinia pseudotuberculosis YopH targets SKAP2-dependent and independent signaling pathways to block neutrophil antimicrobial mechanisms during infection . PLoS Pathog . 16 , e1008576 ( 2020 ). OpenUrl CrossRef PubMed 50. ↵ E. A. Golenkina et al. , Gram-Negative Bacteria Salmonella typhimurium Boost Leukotriene Synthesis Induced by Chemoattractant fMLP to Stimulate Neutrophil Swarming . Front Pharmacol 12 , 814113 ( 2021 ). OpenUrl 51. ↵ P. J. Edqvist , M. Aili , J. Liu , M. S. Francis , Minimal YopB and YopD translocator secretion by Yersinia is sufficient for Yop-effector delivery into target cells . Microbes Infect . 9 , 224 – 233 ( 2007 ). OpenUrl CrossRef PubMed 52. S. Håkansson , T. Bergman , J. C. Vanooteghem , G. Cornelis , H. Wolf-Watz , YopB and YopD constitute a novel class of Yersinia Yop proteins . Infect. Immun . 61 , 71 – 80 ( 1993 ). OpenUrl Abstract / FREE Full Text 53. ↵ S. Hakansson et al. , The YopB protein of Yersinia pseudotuberculosisis essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity . EMBO 15 , 5812 – 5823 ( 1996 ). OpenUrl PubMed Web of Science 54. ↵ R. Rosqvist , A. Forsberg , M. Rimpilainen , T. Bergman , H. Wolf-Watz , The cytotoxic protein YopE of Yersinia obstructs the primary host defence . Mol. Microbiol . 4 , 657 – 667 ( 1990 ). OpenUrl CrossRef PubMed Web of Science 55. ↵ L. Navarro et al. , Identification of a molecular target for the Yersinia protein kinase A . Mol. Cell 26 , 465 – 477 ( 2007 ). OpenUrl CrossRef PubMed 56. ↵ G. Zhang et al. , Spi1 regulates the microglial/macrophage inflammatory response via the PI3K/AKT/mTOR signaling pathway after intracerebral hemorrhage . Neural Regen Res 19 , 161 – 170 ( 2024 ). OpenUrl 57. ↵ J. Krebs , L. B. Agellon , M. Michalak , Ca(2+) homeostasis and endoplasmic reticulum (ER) stress: An integrated view of calcium signaling . Biochem. Biophys. Res. Commun . 460 , 114 – 121 ( 2015 ). OpenUrl CrossRef PubMed 58. M. Prakriya , R. S. Lewis , Store-Operated Calcium Channels . Physiol. Rev. 95 , 1383 – 1436 ( 2015 ). OpenUrl CrossRef PubMed 59. J. W. Putney , T. Tomita , Phospholipase C signaling and calcium influx . Adv Biol Regul 52 , 152 – 164 ( 2012 ). OpenUrl CrossRef PubMed 60. ↵ C. A. Bill , C. M. Vines , Phospholipase C . Adv. Exp. Med. Biol. 1131 , 215 – 242 ( 2020 ). OpenUrl 61. ↵ D. Macmillan , J. G. McCarron , The phospholipase C inhibitor U-73122 inhibits Ca(2+) release from the intracellular sarcoplasmic reticulum Ca(2+) store by inhibiting Ca(2+) pumps in smooth muscle . Br J Pharmacol 160 , 1295 – 1301 ( 2010 ). OpenUrl CrossRef PubMed Web of Science 62. ↵ A. L. Evdonin , I. V. Guzhova , B. A. Margulis , N. D. Medvedeva , Phospholipse c inhibitor, u73122, stimulates release of hsp-70 stress protein from A431 human carcinoma cells . Cancer Cell Int 4 , 2 ( 2004 ). OpenUrl CrossRef PubMed 63. ↵ J. W. M. Heemskerk , R. W. Farndale , S. O. Sage , Effects of U73122 and U73343 on human platelet calcium signalling and protein tyrosine phosphorylation . Biochim. Biophys. Acta 1355 , 81 – 88 ( 1997 ). OpenUrl PubMed 64. ↵ M. A. Hollywood , G. P. Sergeant , K. D. Thornbury , N. G. McHale , The PI-PLC inhibitor U-73122 is a potent inhibitor of the SERCA pump in smooth muscle . Br J Pharmacol 160 , 1293 – 1294 ( 2010 ). OpenUrl CrossRef PubMed 65. ↵ P. W. Reed , H. A. Lardy , A23187: a divalent cation ionophore . J. Biol. Chem . 247 , 6970 – 6977 ( 1972 ). OpenUrl Abstract / FREE Full Text 66. ↵ R. A. Clemens , C. A. Lowell , Store-operated calcium signaling in neutrophils . J. Leukoc. Biol . 98 , 497 – 502 ( 2015 ). OpenUrl CrossRef PubMed 67. ↵ D. El Kebir , L. Jozsef , T. Khreiss , J. G. Filep , Inhibition of K+ efflux prevents mitochondrial dysfunction, and suppresses caspase-3-, apoptosis-inducing factor-, and endonuclease G-mediated constitutive apoptosis in human neutrophils . Cell. Signal . 18 , 2302 – 2313 ( 2006 ). OpenUrl CrossRef PubMed Web of Science 68. ↵ J. R. Yaron et al. , K(+) regulates Ca(2+) to drive inflammasome signaling: dynamic visualization of ion flux in live cells . Cell Death Dis 6 , e1954 ( 2015 ). OpenUrl CrossRef PubMed 69. ↵ J. Roos et al. , STIM1, an essential and conserved component of store-operated Ca2+ channel function . J. Cell Biol . 169 , 435 – 445 ( 2005 ). OpenUrl Abstract / FREE Full Text 70. ↵ J. K. Oliver Werz , Bengt Samuelsson , and Olof Rådmark , 5-Lipoxygenase is phosphorylated by p38 kinase-dependent MAPKAP kinases . PNAS 97 , 5261 – 5266 ( 2000 ). OpenUrl Abstract / FREE Full Text 71. W. H. Waterman , T. F. P. Molski , C. K. Huang , J. L. Adams , R. I. Sha’afi , Tumour necrosis factor-α-induced phosphorylation and activation of cytosolic phospholipase A2 are abrogated by an inhibitor of the p38 mitogen-activated protein kinase cascade in human neutrophils . Biochemistry Journal 319 , 17 – 20 ( 1996 ). OpenUrl Abstract / FREE Full Text 72. ↵ A. W. Ford-Hutchinson , Leukotriene B4 and neutrophil function: a review . Journal ofthe Royal Society of Medicine 74 , 831 – 833 ( 1981 ). OpenUrl 73. ↵ D. Baumann et al. , p38 MAPK signaling in M1 macrophages results in selective elimination of M2 macrophages by MEK inhibition . J Immunother Cancer 9 ( 2021 ). 74. W. Chen et al. , M1 Macrophages Increase Endothelial Permeability and Enhance p38 Phosphorylation via PPAR-gamma/CXCL13-CXCR5 in Sepsis . Int. Arch. Allergy Immunol . 183 , 997 – 1006 ( 2022 ). OpenUrl 75. P. G. Traves et al. , Relevance of the MEK/ERK signaling pathway in the metabolism of activated macrophages: a metabolomic approach . J. Immunol . 188 , 1402 – 1410 ( 2012 ). OpenUrl Abstract / FREE Full Text 76. ↵ Y. Zhou et al. , beta-elemene regulates M1-M2 macrophage balance through the ERK/JNK/P38 MAPK signaling pathway . Commun Biol 5 , 519 ( 2022 ). OpenUrl 77. ↵ D. Ratner et al. , The Yersinia pestis effector YopM inhibits pyrin inflammasome activation . PLoS Pathog . 12 , e1006035 ( 2016 ). OpenUrl CrossRef PubMed 78. ↵ W. W. Lathem , S. D. Crosby , V. L. Miller , W. E. Goldman , Progression of primary pneumonic plague A mouse model of infection, pathology, and bacterial transcriptional activity . PNAS 102 , 17786 – 17791 ( 2005 ). OpenUrl Abstract / FREE Full Text 79. ↵ J. A. Hotinger , H. A. Pendergrass , A. E. May , Molecular Targets and Strategies for Inhibition of the Bacterial Type III Secretion System (T3SS); Inhibitors Directly Binding to T3SS Components . Biomolecules 11 ( 2021 ). 80. ↵ S. R. Waterman , D. W. Holden , Functions and effectors of the Salmonella pathogenicity island 2 type III secretion system . Cell. Microbiol . 5 , 501 – 511 ( 2003 ). OpenUrl CrossRef PubMed Web of Science 81. ↵ A. W. M. van der Velden , S. W. Lindgren , M. J. Worley , F. Heffron , Salmonella pathogenicity island 1-independent induction of apoptosis in infected macrophages by Salmonella enterica Serotype Typhimurium . Infect. Immun . 68 , 5702 – 5709 ( 2000 ). OpenUrl Abstract / FREE Full Text 82. ↵ M. Wang , I. H. Qazi , L. Wang , G. Zhou , H. Han , Salmonella Virulence and Immune Escape . Microorganisms 8 ( 2020 ). 83. ↵ M. N. Marenne , L. Journet , L. J. Mota , G. R. Cornelis , Genetic analysis of the formation of the Ysc-Yop translocation pore in macrophages by Yersinia enterocolitica : role of LcrV, YscF and YopN . Microb. Pathog . 35 , 243 – 258 ( 2003 ). OpenUrl CrossRef PubMed Web of Science 84. ↵ L. Levillayer et al. , SKAP2 Modular Organization Differently Recognizes SRC Kinases Depending on Their Activation Status and Localization . Mol. Cell. Proteomics 22 , 100451 ( 2023 ). OpenUrl CrossRef PubMed 85. ↵ N. Dadwal et al. , The Multiple Roles of the Cytosolic Adapter Proteins ADAP, SKAP1 and SKAP2 for TCR/CD3 - Mediated Signaling Events . Front Immunol 12 , 703534 ( 2021 ). OpenUrl CrossRef 86. ↵ J. Soboloff , B. S. Rothberg , M. Madesh , D. L. Gill , STIM proteins: dynamic calcium signal transducers . Nat Rev Mol Cell Biol 13 , 549 – 565 ( 2012 ). OpenUrl CrossRef PubMed 87. ↵ L. Zheng , P. B. Stathopulos , G. Y. Li , M. Ikura , Biophysical characterization of the EF-hand and SAM domain containing Ca2+ sensory region of STIM1 and STIM2 . Biochem. Biophys. Res. Commun . 369 , 240 – 246 ( 2008 ). OpenUrl CrossRef PubMed Web of Science 88. ↵ O. Werz , D. Szellas , D. Steinhilber , O. Radmark , Arachidonic acid promotes phosphorylation of 5-lipoxygenase at Ser-271 by MAPK-activated protein kinase 2 (MK2) . J. Biol. Chem . 277 , 14793 – 14800 ( 2002 ). OpenUrl Abstract / FREE Full Text 89. ↵ O. Radmark , B. Samuelsson , 5-Lipoxygenase: Mechanisms of regulation . J. Lipid Res . 50 Suppl , S40 – 45 ( 2009 ). OpenUrl Abstract / FREE Full Text 90. ↵ F. A. Amaral et al. , NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B(4) in a murine model of gout . Arthritis Rheum 64 , 474 – 484 ( 2012 ). OpenUrl CrossRef PubMed Web of Science 91. ↵ A. C. G. Salina et al. , Leukotriene B 4 licenses inflammasome activation to enhance skin host defense . Proc. Natl. Acad. Sci. U. S. A . 117 , 30619 – 30627 ( 2020 ). OpenUrl Abstract / FREE Full Text 92. ↵ O. Werz et al. , Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity . Nat Commun 9 , 59 ( 2018 ). OpenUrl CrossRef 93. ↵ C. Haslett , L. A. Guthrie , M. M. Kopaniak , R. B. Johnston Jr ., P. M. Henson , Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide . Am. J. Pathol . 119 ( 1985 ). 94. S. G. Palace , M. K. Proulx , R. L. Szabady , J. D. Goguen , Gain-of-function analysis reveals important virulence roles for the Yersinia pestis type III secretion system effectors YopJ, YopT, and YpkA . Infect. Immun . 86 , 1 – 11 ( 2018 ). OpenUrl CrossRef 95. K. Geddes , M. Worley , G. Niemann , F. Heffron , Identification of new secreted effectors in Salmonella enterica serovar Typhimurium . Infect. Immun . 73 , 6260 – 6271 ( 2005 ). OpenUrl Abstract / FREE Full Text View the discussion thread. Back to top Previous Next Posted July 02, 2024. Download PDF Email Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Distinct Mechanisms of Type 3 Secretion System Recognition Control LTB4 Synthesis in Neutrophils versus Macrophages Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Distinct Mechanisms of Type 3 Secretion System Recognition Control LTB 4 Synthesis in Neutrophils versus Macrophages Amanda Brady , Leonardo C. Mora-Martinez , Benjamin Hammond , Bodduluri Haribabu , Silvia M. Uriarte , Matthew B. Lawrenz bioRxiv 2024.07.01.601466; doi: https://doi.org/10.1101/2024.07.01.601466 Share This Article: Copy Citation Tools Distinct Mechanisms of Type 3 Secretion System Recognition Control LTB 4 Synthesis in Neutrophils versus Macrophages Amanda Brady , Leonardo C. Mora-Martinez , Benjamin Hammond , Bodduluri Haribabu , Silvia M. Uriarte , Matthew B. Lawrenz bioRxiv 2024.07.01.601466; doi: https://doi.org/10.1101/2024.07.01.601466 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Immunology Subject Areas All Articles Animal Behavior and Cognition (7651) Biochemistry (17746) Bioengineering (13928) Bioinformatics (42066) Biophysics (21499) Cancer Biology (18650) Cell Biology (25579) Clinical Trials (138) Developmental Biology (13409) Ecology (19947) Epidemiology (2067) Evolutionary Biology (24374) Genetics (15633) Genomics (22557) Immunology (17775) Microbiology (40505) Molecular Biology (17217) Neuroscience (88796) Paleontology (667) Pathology (2845) Pharmacology and Toxicology (4836) Physiology (7664) Plant Biology (15179) Scientific Communication and Education (2047) Synthetic Biology (4304) Systems Biology (9839) Zoology (2272)